- Home
- PEN vs DCI Comparison
PEN vs DCI Comparison
Compare PEN & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- DCI
- Stock Information
- Founded
- PEN 2004
- DCI 1915
- Country
- PEN United States
- DCI United States
- Employees
- PEN N/A
- DCI N/A
- Industry
- PEN Medical/Dental Instruments
- DCI Pollution Control Equipment
- Sector
- PEN Health Care
- DCI Industrials
- Exchange
- PEN Nasdaq
- DCI Nasdaq
- Market Cap
- PEN 9.0B
- DCI 7.9B
- IPO Year
- PEN 2015
- DCI 1987
- Fundamental
- Price
- PEN $242.93
- DCI $70.86
- Analyst Decision
- PEN Strong Buy
- DCI Hold
- Analyst Count
- PEN 16
- DCI 3
- Target Price
- PEN $300.47
- DCI $70.00
- AVG Volume (30 Days)
- PEN 531.0K
- DCI 514.6K
- Earning Date
- PEN 07-29-2025
- DCI 08-27-2025
- Dividend Yield
- PEN N/A
- DCI 1.69%
- EPS Growth
- PEN 915.21
- DCI N/A
- EPS
- PEN 3.74
- DCI 2.99
- Revenue
- PEN $1,280,152,000.00
- DCI $3,645,600,000.00
- Revenue This Year
- PEN $14.60
- DCI $3.14
- Revenue Next Year
- PEN $14.24
- DCI $3.54
- P/E Ratio
- PEN $64.87
- DCI $23.69
- Revenue Growth
- PEN 12.92
- DCI 3.26
- 52 Week Low
- PEN $160.18
- DCI $57.45
- 52 Week High
- PEN $310.00
- DCI $78.95
- Technical
- Relative Strength Index (RSI)
- PEN 50.26
- DCI 50.30
- Support Level
- PEN $225.48
- DCI $71.64
- Resistance Level
- PEN $261.81
- DCI $72.68
- Average True Range (ATR)
- PEN 6.51
- DCI 1.05
- MACD
- PEN 2.63
- DCI -0.00
- Stochastic Oscillator
- PEN 48.03
- DCI 50.14
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.